Can virulence factors be viable antibacterial targets?

References

• Cazzola M, Matera MG, Page CP. Novelapproaches to the treatment of pneumonia. Trends Phannacol. Sc]. 24(6), 306–314 (2003).
   PubMed Web of Science ®Google Scholar
• Projan SJ. New (and not so new) antibacterial targets-from where and when will the novel drugs come? Carr. Opin. Phannacol. 2,513–522 (2002).
   PubMed Web of Science ®Google Scholar
• ••Excellent analysis of the current state of antibacterials and where to go from here.
   Google Scholar
• Aballay A, Ausubel FM. Caenorhabditis elegans as a host for the study of host-pathogen interactions. Carr. Opin. Microbiol. 5, 97–101 (2002).
   Web of Science ®Google Scholar
• Dionne MS, Ghori N, Schneider DS. Drosophila rnelanogaster is a genetically tractable model host for Mycobacterium marinum Infect. II77177111771 (6), 3540–3550 (2003).
   Google Scholar
• d'Argenio DA, Gallagher LA, Berg CA, Manoil C. Drosophila as a model host for Pseudornonas aeruginosa infection. J. Bacteriology 183(4), 1466–1471 (2001).
   Google Scholar
• Jander G, Rahme LG, Ausubel FM. Positive correlation between virulence of Pseudornonas aeruginosa mutants in mice and insects. J. Bacteriol. 182 (13), 3843–3845 (2000).
   Google Scholar
• Kaito C, Akimitsu N, Watanabe H, Sekimizu K. Silkworm larvae as an animal model of bacterial infection pathogenic to humans. Microb. Pathog. 32(4), 183–190 (2002).
   PubMed Web of Science ®Google Scholar
• Mahajan-Miklos S, Rahme LG, Ausubel FM. Elucidating the molecular mechanisms of bacterial virulence using nonmammalian hosts. Mol. Microbiol. 37(5), 981–988 (2000).
   PubMed Web of Science ®Google Scholar
• •• This review details the multihost pathogenesis model for I? aeruginosa.
   Google Scholar
• Kurz CL, Chauvet S, Andres E, et al. Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivoscreening. EMBO J. 22(7), 1451–1460 (2003).
   Google Scholar
• Garsin DA, Sifri CD, Mylonakis E, et al. A simple model host for identifying Gram-positive virulence factors. Proc. Natl Acad. Sd. 98(19), 10892–10897 (2001).
   PubMed Web of Science ®Google Scholar
• Sifri CD, Begun J, Ausubel FM, Calderwood SB. Caenorhabditis elegans as a model host for Staphylococcus aumus pathogenesis. Infect. II77177111771(4), 2208–2217 (2003).
   Google Scholar
• Alegado RA, Campbell MC, Chen WC, Stutz SS, Tan M-W Characterization of mediators of microbial virulence and innate immunity using the Caenorhabditis elegans host—pathogen model. Cell. Microbiol. 5(7), 435–444 (2003).
   Google Scholar
• Lemaitre B, Reichhart J-M, Hoffmann JA. Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc. Nat/Acad. Sd. 94, 14614–14619 (1997).
   PubMed Web of Science ®Google Scholar
• Tzou P, de Gregorio E, Lemaitre B. How Drosophila combats microbial infection: a model to study innate immunity and host—pathogen interactions. Cum: Opin. Microbiol. 5,102–110 (2002).
   PubMed Web of Science ®Google Scholar
• Kurz CL, Ewbank JJ. Caenorhabditis elegans an emerging genetic model for the study of innate immunity. Nature Rev Genet. 4, 380–390 (2003).
   PubMed Web of Science ®Google Scholar
• Leulier F, Parquet C, Phi-Floury S, et al. The Drosophila immune system detects bacteria through specific peptidoglycan recognition. Nature II7717711170L 4(5), 478–484 (2003).
   Google Scholar
• Buer J, Balling R. Mice, microbes and models of infection. Nature Rev Genet. 4,195–205 (2003).
   PubMed Web of Science ®Google Scholar
• Opperman T, Ling LL, Moir DT Microbial pathogen genomes — new strategies for identifying therapeutic and vaccine targets. Expert Opin. Ther. Targets7 (4), 469–473 (2003).
   Google Scholar
• Hensel M, Shea JE, Gleeson C, et al. Simultaneous identification of bacterial virulence genes by negative selection. Science 269,400–403 (1995).
   PubMed Web of Science ®Google Scholar
• Perry RD. Signature-tagged mutagenesis and the hunt for virulence factors. Trends Microbiol. 7(10), 385–388 (1999).
   PubMed Web of Science ®Google Scholar
• Shea JE, Santagelo JD, Feldman RG. Signature-tagged mutagenesis in the identification of virulence genes in pathogens. Curr. Opin. Microbiol. 3,451–458 (2000).
   PubMed Web of Science ®Google Scholar
• Lehoux DE, Levesque RC. Detection of genes essential in specific niches by signature-tagged mutagenesis. Cum: Opin. BiotechnoL 11, 434–439 (2000).
   Google Scholar
• Chiang SL, Mekalanos JJ, Holden DVV. In vivo genetic analysis of bacterial virulence. Ann. Rev Microbiol. 53,129–154 (1999).
   PubMed Web of Science ®Google Scholar
• •Good review of WET and STM to understand host—pathogen interactions.
   Google Scholar
• Polissi A, Pontiggia A, Feger G, et al. Large-scale identification of virulence genes from Streptococcus pneurnoniae. Infect. Immun 66(12), 5620–5629 (1998).
   PubMed Web of Science ®Google Scholar
• Lau GVV, Haataja S, Lonetto M, et al. A functional genomic analysis of Type 3 Streptococcus pneurnoniae virulence. Mol. Microbiol. 40(3), 555–571 (2001).
   Google Scholar
• Hava DL, Camilli A. large-scale identification of serotype 4 Streptococcus pneurnoniae virulence factors. Mol. MicrobioL 45(5), 1389–1405 (2002).
   Google Scholar
• Mecsas J. Use of signature-tagged mutagenesis in pathogenesis studies. Cum: Opin. Microbiol. 5,33–37 (2002).
   PubMed Web of Science ®Google Scholar
• Coulter SN, Schwan WR, Ng EY, et al. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol. NlicrobioL 30(2), 393–404 (1998).
   Google Scholar
• Angelichio MJ, Camilli A. in vivo expression technology. Infect. 11771771117.. 70 (12), 6518–6523 (2002).
   Google Scholar
• Rankin S, Isberg R. Identification of Legionella pneurnophila promoters regulated by the macrophage intracellular environment. Infect. Agents Dis. 2(4), 269–271 (1993).
   Google Scholar
• Rankin S, Li Z, Isberg RR. Macrophage-induced genes of Legionella pneurnophila: protection from reactive intermediates and solute imbalance during intracellular growth. Infect. Irnmun 70 (7), 3637–3648 (2002).
   Web of Science ®Google Scholar
• Mahan MJ, Slauch JM, Mekalanos JJ. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259,686–688 (1993).
   PubMed Web of Science ®Google Scholar
• Mahan MJ, Tobias JW, Slauch JM, Hanna PC, Collier RJ. Antibiotic-based selection for bacterial genes that are specifically induced during infection of a host. Proc. Natl Acad. Sc]. 92,669–673 (1995).
   PubMed Web of Science ®Google Scholar
• Kiliç A, Herzberg M, Meyer M, Zhao Z, Tao L. Streptococcal reporter gene-fusion vector for identification of in vivo expressed genes. Plasrnid 42(1), 67–72 (1999).
   PubMed Web of Science ®Google Scholar
• Camilli A, Beattie DT, Mekalanos JJ. Use of genetic recombination as a reporter of gene expression. Proc. Natl Acad. Sc]. 91, 2634–2638 (1994).
   PubMed Web of Science ®Google Scholar
• Camilli A, Mekalanos J. Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection. Mol. Microbiol. 18,671–683 (1995).
   PubMed Web of Science ®Google Scholar
• Lee S, Butler S, Camilli A. Selection for in vivo regulators of bacterial virulence. Proc. Natl Acad. Sc]. 98(12), 6889–6894 (2001).
   PubMed Web of Science ®Google Scholar
• •Describes the use of RIVET to identify positive regulators of virulence genes during an actual infection.
   Google Scholar
• Marra A, Asundi J, Bartilson M, et al. Differential fluorescence induction analysis of Streptococcus pneurnoniae identifies genes involved in pathogenesis. Infect. Immun 70 (3), 1422–1433 (2002).
   Google Scholar
• Badger J, Wass C, Kim K. Identification of Escherichia coil K1 genes contributing to human brain microvascular endothelial cell invasion by differential fluorescence induction. Mol. Microbiol. 36(1), 174–182 (2000).
   Google Scholar
• Schneider WP, Ho SK, Christine J, et al. Virulence gene indentification by differential fluorescence induction analysis of Staphylococcus aureus gene expression during infection-simulating culture. Infect. Immun 70(3), 1326–1333 (2002).
   Google Scholar
• Valdivia RH, Falkow S. Bacterial genetics by flow cytometry: rapid isolation of Salmonella typhinturium acid-inducible promoters by differential fluorescence induction. Mol. Microbiol. 22 (2), 367–378 (1996).
   Google Scholar
• Mason KM, Munson RS, Jr., Bakaletz LO. Nontypeable Haernophilus influenzae gene expression induced in vivo in a chinchilla model of otitis media. Infect. Irnmun 71(6), 3454–3462 (2003).
   Google Scholar
• Cummings CA, Relman DA. Using DNA microarrays to study host—microbe interactions. Erner. Infect. Dis. 6(5), 513–525 (2000).
   Web of Science ®Google Scholar
• Kato-Maeda M, Gao Q, Small PM. Microarray analyis of pathogens and their interactions with hosts. Cell. Microbiol. 3(11), 713–719 (2001).
   PubMed Web of Science ®Google Scholar
• Haney SA, Alksne LE, Dunman PM, Murphy E, Projan SJ. Genomics in anti-infective drug discovery — getting to endgame. Carr. Pharmaceutical Design 8, 1099–1118 (2002).
   PubMed Web of Science ®Google Scholar
• Sassetti C, Rubin EJ. Genomic analyses of microbial virulence. Cum Opin. Microbiol. 5, 27–32 (2002).
   PubMed Web of Science ®Google Scholar
• Deb DK, Dahiya P, Srivastava KK, Srivastava R, Srivastava BS. Selective identification of new therpeutic targets of Mycobacterium tuberculosis by IVIAT approach. Tuberculosis (Edirrb) 82 (4–5), 175–82 (2002).
   Google Scholar
• Kim YR, Lee SE, Kim CM, et al. Characterization and pathogenic significance of Vibrio vulnifkus antigens preferentially expressed in septicemic patients. Infect. 1177177111771(10), 5461–5471 (2003).
   Google Scholar
• Etz H, Minh DB, Henics T, et al. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc. Natl Acad. Scir. 99(10), 6573–6578 (2002).
   PubMed Web of Science ®Google Scholar
• Hang L, John M, Asaduzzaman M, et al. Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae. Proc. Natl Acad. Scir. 100(14), 8508–8513 (2003).
   PubMed Web of Science ®Google Scholar
• Wizemann TM, Heinrichs JH, Adamou JE, et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneurnoniae. Infect. II77177111769 (3), 1593–1598 (2001).
   Google Scholar
• Li Y, Frey E, Mackenzie AMR, Finlay BB. Human response to Ercherichia co/i0157:H7 infection: antibodies to secreted virulence factors. Infect. Irnrnun 68(9), 5090–5095 (2000).
   Google Scholar
• Kernodle DS, Voladri RKR, Menzies BE, Hager CC, Edwards KM. Expresison of antisense hla fragment in Staphylococcus aumus reduces alpha-toxin production in vitro and attentuates lethal activity in a murine model. Infect. II77177111765(1), 179–184 (1997).
   Google Scholar
• •First report on the use of antisense to modulate gene activity in vivo.
   Google Scholar
• Ji Y, Marra A, Rosenberg M, Woodnutt G. Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aumus infection. J. BacterioL 181 (21), 6585–6590 (1999).
   Google Scholar
• Ji Y, Zhang B, Van Horn SF, et al. Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293, 2266–2269 (2001).
   PubMed Web of Science ®Google Scholar
• Macielag M, Goldschmidt R. Inhibitors of bacterial two-component signalling systems. Expert Opin. Invest. Drugs 9(10), 2351–2369 (2000).
   PubMed Web of Science ®Google Scholar
• Barrett JF, Goldschmidt RM, Lawrence LE, et al. Antibacterial agents that inhibit two-component signal transduction systems. Proc. Natl Acad. Sci. 95, 5317–5322 (1998).
   PubMed Web of Science ®Google Scholar
• Barrett JF, Hoch JA. Two-component signal transduction as a target for microbial anti-infective therapy. Antirnicrob. Agents Chernother. 42(7), 1529–1536 (1998).
   PubMed Web of Science ®Google Scholar
• ••This article puts forth sound arguments fortargeting TCSTSs.
   Google Scholar
• Wallis NG. Bacterial two-component signal transduction systems as drug targets. Carr. Opin. Anti-infect. Invest. Drugsl (4), 428–434 (1999).
   Google Scholar
• ••Discusses the arguments for targetingTCSTSs.
   Google Scholar
• Stephenson K, Hoch JA. Virulence-and antibiotic resistance-associated two-component signal transduction systems of Gram-positive pathogenic bacteria as targets for antimicrobial therapy. PharrnacoL Ther. 93, 293–305 (2002).
   PubMed Web of Science ®Google Scholar
• Throup JP, Koretke KK, Bryant AP, et al. A genomic analysis of two-component signal transduction in Streptococcus pneurnoniae. Mol. Microbiol. 35(3), 566–576 (2000).
   PubMed Web of Science ®Google Scholar
• Blue CE, Mitchell TJ. Contribution of a response regulator to the virulence of Streptococcus pneurnoniae is strain dependent. Infect. Irnmun 71(8), 4405–4413 (2003).
   Google Scholar
• Panthel K, Dietz P, Haas R, Beier D. Two-component systems of Helicobacter pylori contribute to virulence in a mouse infection model. Infect. Irnmun 71 (9), 5381–5385 (2003).
   PubMed Web of Science ®Google Scholar
• Kreikemeyer B, McIver KS, Podbielski A. Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen—host interactions. Trends Microbiol. 11(5), 224–232 (2003).
   Google Scholar
• Parish T, Smith DA, Kendall S, et al. Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infect. Irnmun 71(3), 1134–1140 (2003).
   PubMed Web of Science ®Google Scholar
• Hueck C. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62, 379–433 (1998).
   PubMed Web of Science ®Google Scholar
• Muller S, Feldman MF, Cornelis GR. The Type III secretion system of Gram-negative bacteria: a potential therapeutic target. Expert Opin. Ther. Targets 5(3), 327–339 (2001).
   PubMedGoogle Scholar
• Winstanley C, Hart CA. Type III secretion systems and pathogenicity islands. J. Med. Microbiol. 50, 116–126 (2001).
   PubMed Web of Science ®Google Scholar
• Miyata S, Casey M, Frank DW, Ausubel FM, Drenkard E. Use of the Galleria rnellonella caterpillar as a model host to study the role of the Type III secretion system in Pseudornonas aeruginosa pathogenesis. Infect. Irnmun 71 (5), 2402–2413 (2003).
   Google Scholar
• Kauppi AM, Nordfelth R, Uvell H, Wolf-Watz H, Elofsson M. Targeting bacterial virulence: inhibitors of Type III secretion in Yersinia. Chem. Biol. 10, 241–249 (2003).
   PubMed Web of Science ®Google Scholar
• Donlan R, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Can. Microbiol. Rev. 15(2), 167–193 (2002).
   PubMed Web of Science ®Google Scholar
• •Centers on the importance of biofilms in human disease.
   Google Scholar
• Dunne WM Jr. Bacterial adhesion: seen any good biofilms lately? Clin. Microbiol. Rev. 15(2), 155–166 (2002).
   PubMed Web of Science ®Google Scholar
• Costerton JVV, Stewart PS, Greenberg EE Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322 (1999).
   PubMed Web of Science ®Google Scholar
• Ehrlich GD, Veeh R, Wang X, et al. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. jAm. Med. Assoc. 287(13), 1710–1715 (2002).
   Google Scholar
• Davies D. Understanding biofilm resistance to antibacterial agents. Nature Reviews Drug Discovery 2, 114–122 (2003).
   PubMed Web of Science ®Google Scholar
• Leid JG, Shirtliff ME, Costerton JVV, Stoodley E Human leukocytes adhere to, penetrate and respond to Staphylococcus aumus biofilms. Infect. Irnmun 70 (11), 6339–6345 (2002).
   Google Scholar
• Murphy TF, Kirkham C. Biofilm formation by nontypeable Haernophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC MicrobioL 2, 7–15 (2002).
   PubMed Web of Science ®Google Scholar
• Schembri MA, Kjaergaard K, Klemm E Global gene expression in Escherichia coil biofilms. Mol. Microbiol. 48(1), 253–267 (2003).
   Google Scholar
• Hentzer M, Ebert L, Nielsen J, Givskov M. Quorum sensing: a novel target for the treatment of biofilm infections. Biodrugs 17(4), 241–250 (2003).
   PubMed Web of Science ®Google Scholar
• Camara M, Williams P, Hardman A. Controlling infection by tuning in and turning down the volume of bacterial small-talk. Lancet Inlèct.Dis. 2, 667–676 (2002).
   Web of Science ®Google Scholar
• Wu H, Song Z, Hentzer M, et al. Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudornonas aeruginosa. Microbiol. 146, 2481–2493 (2000).
   PubMed Web of Science ®Google Scholar
• Ward C, Camara M, Forrest I, et al. Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients. Thorax 58, 444–446 (2003).
   PubMed Web of Science ®Google Scholar
• Hentzer M, Riedel K, Rasmussen TB, et al. Inhibition of quorum sensing in Pseudornonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbia 148, 87–102 (2002).
   PubMed Web of Science ®Google Scholar
• Hentzer M, Wu H, Anderson JB, et al. Attentuation of Pseudornonas aeruginosa virulence by quorum sensing inhibitors. EMBO 22(15), 3803–3815 (2003).
   Google Scholar
• Bassler BL, Greenberg EP, Stevens AM. Cross-species induction of luminescence in the quorum-sensing bacterium Vibrio harveyi. Bacteria 179(12), 4043–4045 (1997).
   PubMed Web of Science ®Google Scholar
• Ji G, Beavis RC, Novick RE Bacterial interference caused by autoinducing peptide variants. Science 276, 2027–2030 (1997).
   PubMed Web of Science ®Google Scholar
• Balaban N, Goldkorn T, Nhan RT, et al. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus Science 280, 438–440 (1998).
   Google Scholar
• Hartman G, Wise R. Quorum sensing: potential means of treating Gram-negative infections? Lancet 351, 848–849 (1998).
   PubMed Web of Science ®Google Scholar
• Bauer WB, Robinson JB. Disruption of bacterial quorum sensing by other organisms. Curr. Opin. Biotech. 13(3), 234–237 (2002).
   PubMed Web of Science ®Google Scholar
• Balaban N, Giacometti A, Cirioni O, et al. Use of the quroum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epiderrnidis.. 1. Infect. Dis. 187, 625–630 (2003).
   Google Scholar
• Dong Y-H, Wang L-H, Xu J-L, et al. Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase. Nature 411, 813–817 (2001).
   PubMed Web of Science ®Google Scholar
• Finch RG, Pritchard DI, Bycroft BW, Williams E Stewart GSAB. Quorum sensing: a novel target for anti-infective therapy.. 1. Antirnicrob. Chernother. 42, 569–571 (1998).
   Google Scholar
• Winzer K, Williams P Quorum sensing and the regulation of virulence gene expression in pathogenic bacteria. Int.. 1. Med. Microbiol. 291, 131–143 (2001).
   Google Scholar
• Williams P Quorum sensing: an emerging target for antibacterial chemotherapy? Expert Opin. Ther. Targets 6(3), 257–274 (2002).
   PubMedGoogle Scholar
• Kohler T, Van Delden C, Curty LK, Hamzehpour MM, Pechere J-C. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signalling in Pseudornonas aeruginosa. Bacteria 183(18), 5213–5222 (2001).
   Google Scholar
• Sanchez P, Linares JF, Ruiz-Diez B, et al. Fitness of in vitro selected Pseudornonas aeruginosa nalBand nbrBmultidrug resistant mutants.. 1. Antirnicrob. Chernother. 50, 657–664 (2002).
   Google Scholar
• Hirakata Y, Srikumar R, Poole K, et al. Multidrug efflux systems play an important role in the invasiveness of Pseudornonas aeruginosa. Exp. Med. 196(1), 109–118 (2002).
   Google Scholar
• Rahmati S, Yang S, Davidson AL, Zechiedrich EL. Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA. Mol. Microbia 43(3), 677–685 (2002).
   PubMed Web of Science ®Google Scholar
• Smith JN, Ahmer BMM. Detection of other microbial species by Sa/monella: expression of the SdiA regulon. j Bacteriol. 185(4), 1357–1366 (2003).
   Google Scholar
• Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl.. 1. Med. 348 (14), 1342–1347 (2003).
   Google Scholar
• Goldschmidt R, Macielag M, Hlasta D, Barrett J. Inhibition of virulence factors in bacteria. Carr. Pharrn. Design 3 125–142 (1997).
   Web of Science ®Google Scholar
• •• This review presents thorough pros and cons of using bacterial virulence factors as appropriate targets for antibacterial therapy.
   Google Scholar
• Alksne LE. Virulence as a target for antimicrobial chemotherapy. Expert Opin. Invest. Drugsll (8), 1149–1159 (2002).
   PubMed Web of Science ®Google Scholar
• ••Presenting the pros and cons of usingbacterial virulence factors as appropriate targets for antibacterial therapy.
   Google Scholar
• Coates A, Hu Y, Bax R, Page C. The future challenges facing the development of new antimicrobial drugs. Nature Reviews Drug Discoveryl, 895–910 (2002).
   PubMed Web of Science ®Google Scholar